REFRACTORY MALIGNANT NEOPLASM OF MULTIPLE PRIMARY SITES

Clinical trials for REFRACTORY MALIGNANT NEOPLASM OF MULTIPLE PRIMARY SITES explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY MALIGNANT NEOPLASM OF MULTIPLE PRIMARY SITES trials appear

Sign up with your email to follow new studies for REFRACTORY MALIGNANT NEOPLASM OF MULTIPLE PRIMARY SITES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Donor immune cells tested as new weapon against tough childhood cancers

Disease control Terminated

This early-stage study tested a new combination treatment for children and young adults whose solid tumors had returned or stopped responding to standard therapies. Researchers gave patients chemotherapy followed by immune cells (called NK cells) donated from umbilical cord blood…

Matched conditions: REFRACTORY MALIGNANT NEOPLASM OF MULTIPLE PRIMARY SITES

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 02, 2026 02:27 UTC

REFRACTORY MALIGNANT NEOPLASM OF MULTIPLE PRIMARY SITES

Get alerted when new REFRACTORY MALIGNANT NEOPLASM OF MULTIPLE PRIMARY SITES trials appear

Donor immune cells tested as new weapon against tough childhood cancers